Echo Street Capital Management LLC Guardant Health, Inc. Transaction History

Echo Street Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$25.8 - $39.97 $671,264 - $1.04 Million	26,018 New	26,018 $771,000
Q4 2022 Feb 13, 2023	BUY	$25.44 - $59.78 $902,763 - $2.12 Million	35,486 New	35,486 $965,000
Q2 2022 Aug 15, 2022	BUY	$28.82 - $77.35 $494,176 - $1.33 Million	17,147 New	17,147 $692,000
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $547,284 - $732,353	-5,541 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$109.77 - $165.68 $450,386 - $679,785	4,103 Added 285.33%	5,541 $688,000
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $586,289 - $826,546	-4,615 Reduced 76.24%	1,438 $220,000
Q4 2020 Feb 16, 2021	BUY	$99.96 - $135.93 $605,057 - $822,784	6,053 New	6,053 $780,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.